Improving Meibomian Gland Dysfunction with Device Management

Improving Meibomian Gland Dysfunction with Device Management

Improving Meibomian Gland Dysfunction with Device Management

What can be done besides warm compresses and artificial tears for dry eye disease? Tune in for expert strategies that can help your patients.

Available credits: 0.25

Time to complete: 15 minutes


Valid until:

Take Post-Test

If you’ve already completed the activity.

  • Overview

    How can more advanced measures improve meibomian gland function to relieve dry eye symptoms and improve refraction? Listen as Dr. Cynthia Matossian and Dr. Jillian Ziemanski discuss additional approaches you can try with your patients.

  • Disclosure of Conflicts of Interest

    In accordance with the ACCME Standards for Integrity and Independence, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company. GLC mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

    Cynthia Matossian, MD, FACS
    Founder and Medical Director
    Matossian Eye Associates
    Doylestown, PA
    Hopewell, NJ

    Consulting Fees: ACET, Aerie Pharmaceuticals, Alcon, Allergan, Aramis Biosciences, Avellino, Bausch + Lomb, BlephEx, Bruder Healthcare, CheckedUp, Conclusn, CSI Dry Eye, Dompe, ESW, EyePoint, Glint Pharmaceuticals, GPOphtho, Guardion Health Sciences, Hilco, I-MED Pharma, Imprimis Pharmaceuticals, Johnson & Johnson, Kala Pharmaceuticals, LacriSciences Vision, Legrande Health, Lenstec, Lumenis, Marco, MDbackline, MiCare, MYZE, Novartis, NuLids LLC, Ocular Science, Olympic, Physician Recommended Nutraceuticals, Quidel, Rayner, Regener-Eyes, RVL, Scope, Santen, StepWise Medical, Sun Pharmaceuticals, TearLab, TearScience (J&J), Thea Pharma, TissueTech, Visionology, Visiox, Visus Therapeutics, Zeiss
    Ownership Interest: CheckedUp, Strathspey Crown, Veterinarian Recommended Solutions
    Research: Dompe, Imprimis Pharmaceuticals, Johnson & Johnson, Novartis

    Jillian Ziemanski, OD, PhD, FAAO
    Clinical Assistant Professor
    UAB School of Optometry
    The University of Alabama at Birmingham
    Birmingham, AL

    No relevant relationships to report

    Reviewers/Content Planners/Authors:

    • Jennifer Brutsche has nothing to disclose.
    • Cindy Davidson has nothing to disclose.
    • Robert Schneider has nothing to disclose.
    • Mara Siegel has nothing to disclose.
    • Stephanie Wenick has nothing to disclose.
  • Learning Objectives

    After participating in this educational activity, participants should be better able to:

    • Interpret clinical trial data supporting the safety and efficacy of device therapy to treat meibomian gland dysfunction
  • Target Audience

    This activity is designed to meet the educational needs of ophthalmologists and optometrists.

  • Accreditation and Credit Designation Statements

    In support of improving patient care, Global Learning Collaborative (GLC) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


    Global Learning Collaborative is accredited by COPE to provide continuing education to optometrists.

    Global Learning Collaborative (GLC) designates this enduring activity for a maximum of .25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Global Learning Collaborative (GLC) designates this activity for .25 nursing contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

    This course is COPE approved for .25 of CE credit. Course ID is 82592-TD. Check with your local state licensing board to see if this counts toward your CE requirement for relicensure.

  • Provider(s)/Educational Partner(s)

    Prova Education designs and executes continuing education founded on evidence-based medicine, clinical need, gap analysis, learner feedback, and more. Our mission is to serve as an inventive and relevant resource for clinical content and educational interventions across a broad spectrum of specialties.

    Prova Education's methodology demonstrates a commitment to continuing medical education and the innovative assessment of its effects. Our goal is clear—to develop and deliver the very best education in the most impactful manner and to verify its results with progressive outcomes research.

    This activity is provided in partnership with the National Eye Institute, of the National Institutes of Health, of the US Department of Health and Human Services. The National Eye Health Education Program of the NEI is acknowledged for its important contributions to this initiative.

  • Commercial Support

    This activity is supported by an independent educational grant from Johnson & Johnson.

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and Prova Education. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of Prova Education you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.

    Reproduction Prohibited
    Reproduction of this material is not permitted without written permission from the copyright owner.

  • System Requirements

    Our site requires a computer, tablet, or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/Cable/Fibre). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Chrome, Safari, Firefox, or Microsoft Edge.

Facebook Comments


We’re glad to see you’re enjoying Eye Health Academy…
but how about a more personalized experience?

Register for free